Top Markets
Coin of the day
Karuna Therapeutics, Inc. Karuna Therapeutics, Inc.

Karuna Therapeutics, Inc.

KRTX
Rank in Stocks #2198
Operating as a clinical-stage biopharmaceutical firm, Karuna Therapeutics, Inc.... Operating as a clinical-stage biopharmaceutical firm, Karuna Therapeutics, Inc. is dedicated to pioneering innovative therapies for individuals afflicted by psychiatric and neurological disorders. Its primary investigational compound, KarXT, is an oral agent designed to modulate muscarinic receptors. Currently in Phase III clinical trials, KarXT is being evaluated for several indications: the treatment of acute psychosis in schizophrenia patients, the amelioration of central nervous system conditions (including the negative and cognitive symptoms associated with schizophrenia and general psychosis), and the management of dementia-related psychosis. Beyond KarXT, the firm is also advancing a pipeline of other drug candidates that interact with muscarinic receptors. Karuna Therapeutics, Inc. has forged several strategic partnerships, encompassing licensing agreements with Eli Lilly and Company and Zai Lab (Shanghai) Co., Ltd., a patent license with PureTech Health LLC, and drug discovery collaborations with Charles River Laboratories and PsychoGenics, Inc. Established in 2009, the enterprise initially operated under the name Karuna Pharmaceuticals, Inc., before officially adopting its current corporate identity, Karuna Therapeutics, Inc., in March 2019. Its corporate headquarters are located in Boston, Massachusetts.
Share Price
$329.83
Last synced: 2024-03-18
Market Cap
$9.75B
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Karuna Therapeutics, Inc. (KRTX)

Category

Stock price history for Karuna Therapeutics, Inc. (KRTX)
Highest end of day price: $321.83 on 2024-03-01

Lowest end of day price: $20.02 on 2019-06-01
Stock price history of Karuna Therapeutics, Inc. from 2019 to 2026
Annual Stock Price Performance
Year Performance
2024 35.70%
2023 16.25%
2022 66.79%
2021 21.64%
2020 40.61%
2019 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$553.98 42.43%
US
$1.03K 51.58%
NL
$156.19 516.13%
US
$122.47 -12.71%
AU
$774.87 9.04%
CH